Clinical Report: Management of Recurrent IgG4-Related Hypertrophic Pachymeningitis
Overview
This report details a case of recurrent IgG4-related hypertrophic pachymeningitis (IgG4-RHP) in a 63-year-old female patient who initially responded well to decompression surgery and steroid therapy. Following disease recurrence after steroid withdrawal, a combination of oral prednisolone and azathioprine led to significant clinical improvement and resolution of MRI findings.
Background
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition that can affect various organs, including the central nervous system. IgG4-RHP is a rare manifestation that can lead to significant neurological deficits if not properly managed. Understanding the management strategies for recurrent cases is crucial for improving patient outcomes.
Data Highlights
No numerical data or trial data was presented in the article.
Key Findings
The patient achieved near-complete recovery of motor function post-surgery.
Recurrence of symptoms occurred after discontinuation of steroid therapy due to side effects.
Combination therapy with prednisolone and azathioprine resulted in significant clinical improvement after 6 months.
Interval MRI scans showed resolution of the lesion and normalization of serum IgG4 levels.
Surgical decompression is essential in cases of acute neurological deterioration.
Long-term maintenance therapy is critical to prevent relapse in IgG4-RHP.
Clinical Implications
Clinicians should consider IgG4-RHP in the differential diagnosis of long-segment epidural masses. A combination of steroids and immunomodulatory agents may be necessary for managing recurrent cases, and careful monitoring for side effects of steroid therapy is essential.
Conclusion
This case underscores the importance of a multidisciplinary approach in managing recurrent IgG4-RHP, highlighting the efficacy of combined surgical and medical therapies in achieving favorable outcomes.
